Next Article in Journal
Compressive Properties and Degradable Behavior of Biodegradable Porous Zinc Fabricated with the Protein Foaming Method
Next Article in Special Issue
Effect of Different Cavity Disinfectants on Adhesion to Dentin of Permanent Teeth
Previous Article in Journal
DLP Fabrication of Zirconia Scaffolds Coated with HA/β-TCP Layer: Role of Scaffold Architecture on Mechanical and Biological Properties
Previous Article in Special Issue
Histologic Evaluation of the Effects of Folinic Acid Chitosan Hydrogel and Botulinum Toxin A on Wound Repair of Cleft Lip Surgery in Rats
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Development and Physicochemical Characterization of Eugenia brejoensis Essential Oil-Doped Dental Adhesives with Antimicrobial Action towards Streptococcus mutans

by
Maury Luz Pereira
1,
Danyelle Cristina Pereira Santos
1,
Carlos Alberto Mendes Soares Júnior
2,
Tamyris Alicely Xavier Nogueira Bazan
2,
Clovis Macêdo Bezerra Filho
3,
Márcia Vanusa da Silva
3,
Maria Tereza dos Santos Correia
3,
Andres Felipe Millan Cardenas
2,
Fabiana Suelen Figuerêdo de Siqueira
2,
Edilausson Moreno Carvalho
2,
Bruna Marin Fronza
4,
Carolina Bosso André
5,
Luis Claudio Nascimento da Silva
1,2 and
Lívia Câmara de Carvalho Galvão
1,2,*
1
Postgraduate Program in Microbial Biology, CEUMA University, São Luís 65075-120, MA, Brazil
2
Postgraduate Program in Dentistry, CEUMA University, São Luís 65075-120, MA, Brazil
3
Department of Biochemistry, Federal University of Pernambuco, Recife 50751-310, PE, Brazil
4
Department of Biomaterials and Oral Biology, School of Dentistry, University of São Paulo, São Paulo 05508-270, SP, Brazil
5
Department of Restorative Dentistry, Operative Dentistry Division, Federal University of Minas Gerais, Belo Horizonte 30130-100, MG, Brazil
*
Author to whom correspondence should be addressed.
J. Funct. Biomater. 2022, 13(3), 149; https://doi.org/10.3390/jfb13030149
Submission received: 17 July 2022 / Revised: 26 August 2022 / Accepted: 27 August 2022 / Published: 13 September 2022
(This article belongs to the Special Issue Feature Papers in Dental Biomaterials)

Abstract

:
Dental caries is a multifactorial, biofilm-dependent infectious disease that develops when detrimental changes occur in the oral cavity microenvironment. The antimicrobial and antivirulence properties of the essential oil obtained from the leaves of Eugenia brejoensis Mazine (EBEO) have been reported against Gram-positive and Gram-negative bacteria. Herein, the antimicrobial action of EBEO towards Streptococcus mutans is reported, along with the development and characterization of dental adhesives doped with. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of EBEO were determined against S. mutans, while its toxicity was analyze using Tenebrio molitor larvae. EBEO (MIC and 10×MIC) was incorporated into the Ambar Advanced Polymerization System® (Ambar APS), a two-step total-etch adhesive system (FGM Dental Group), and the antibiofilm action was evaluated. The reflective strength, modulus of elasticity, degree of conversion, and maximum rate of polymerization of each adhesive were also determined. The MIC and MBC values of EBEO against S. mutans were 62.5 µg/mL. The tested concentrations of EBEO were non-toxic to T. molitor larvae. The formation of S. mutans biofilms was significantly inhibited by EBEO and EBEO-coated resin discs (p < 0.05). Importantly, EBEO incorporation did not affect the mechanical and physicochemical properties in relation to oil-free adhesive version. EBEO showed strong antibacterial and antibiofilm activity against S. mutans, no toxicity effect against T. molitor larvae, and did not jeopardize the physical-chemical properties tested.

1. Introduction

Dental caries is a multifactorial, biofilm-dependent infectious disease that develops when detrimental changes occur in the oral cavity microenvironment [1,2]. It is characterized by an increase in the growth of cariogenic microorganisms (mainly, the genera Streptococci, Lactobacillus, Actinomyces, Bifidobacteria, Candida, Veillonella, and Prevotella) [3,4,5]. These pathogens are highly efficient at converting carbohydrates into organic acids, causing the demineralization of dental tissues [6]. The risk factors for dental caries involve poor oral hygiene, xerostomia, bad eating habits, food disorders, a lack of preventive dental care, and the alteration of the oral microbiota [7].
Among the microorganisms present in the oral cavity, Streptococcus mutans is the most related to the appearance of primary and secondary carious lesions and is therefore considered the main etiological agent of dental caries [8,9]. S. mutans can colonize tooth surfaces and form biofilms without the presence of glucose. In fact, S. mutans is the main producer of extracellular matrix (EM) in dental biofilm due its encoded glucosyltransferases, which enable the production of extracellular polysaccharides, promoting the adhesion of other microorganisms [5,8,10]. S. mutans can also metabolize a wide variety of carbohydrates to produce acids. Moreover, S. mutans can survive in low pH environments. Together, these characteristics are key virulence factors for S. mutans in dental caries [9,11,12]. There are also several virulence mechanisms that facilitate the survival and selection of S. mutans as a dominant strain under stressful conditions, such as dramatic pH changes, osmolarity differences, poor nutrient availability, and the presence of reactive oxygen species [9].
Recurrent (or secondary) caries, characterized by the recurrence of infection in restored teeth, are among the main causes of restoration replacement [13]. Thus, the association of antimicrobial agents with adhesive systems or composite resins is useful for preventing secondary caries [14,15]. The main advantage of incorporating an antimicrobial agent into the materials is the decrease in bacterial colonization, reducing the acid production, which causes dental demineralization, thus reducing the likelihood of restoration replacement [16,17]. Moreover, some studies have reported that the incorporation of antimicrobial agents, such as chlorhexidine, doxycycline, silver nanoparticles, monomers based on quaternary ammonium, or even isolated from natural products as apigenin and tt-farnesol, may benefit restorative procedures [17,18,19,20,21,22].
The essential oils (EO) are examples of antimicrobial agents incorporated in adhesive systems [23,24,25]. They are defined as complex mixtures of different chemical compounds (20–80 different molecules) that have attracted attention due their unique functional properties, for instance, they that can interact with various bacterial targets, such as membranes, protein synthesis, and efflux pumps, as well as virulence-related targets, such as biofilm formation [26,27,28].
The plants from the Eugenia genus are known to bear an essential oil, with several pharmacological potentials such as antioxidant, antitumoral, and antimicrobial activities [29]. In 2008, a novel species of Eugenia was discovered in the wetlands of the Pernambuco (Brazil), a place popularly known as “brejos”. Based on the location of its first description, this plant was named Eugenia brejoensis Mazine [30]. The essential oil purified from this plant (EBEO) has been found to exhibit potential larvicidal and antimicrobial effects against gram-positive bacteria [31,32,33]. EBEO is mainly composed of sesquiterpenes, such as δ-cadinene, β-caryophyllene, α-muurolol, α-cadinol, and bicyclogermacrene [33].
To develop new dental materials with better physical, chemical, and biological properties, with the aim of increasing the longevity of restorations and avoiding secondary caries, the present study evaluated the antibacterial and antibiofilm effects and toxicity of the essential oil derived from E. brejoensis Mazine (EBEO), along with the antibacterial and physicochemical properties of a commercial dental adhesive doped with EBEO at different concentrations. The null hypotheses were that EBEO (1) would not present a bactericidal and antibiofilm effect; (2) would not present toxicity effect; (3) when added to a dental adhesive would not present antibiofilm effects; and (4) when added to a dental adhesive would not affect it physical-chemical properties.

2. Results

2.1. EBEO Has Antibacterial Activity against Streptococcus mutans

Microdilution assays were performed to the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of EBEO against S. mutans. The EBEO had a MIC of 62.5 µg/mL. The MBC of EBEO coincided with the MIC, resulting in a MBC:MIC ratio of 1, which indicated a bactericidal effect.

2.2. EBEO Inhibits the Formation of Streptococcus mutans Biofilm

The anti-biofilm action of EBEO was evaluated in an assay using circular glass slides. In the control group, in which the biofilm was formed without of EBEO interference, biofilm production by S. mutans was abundant (Figure 1A). In groups where EBEO was used at MIC (62.5 µg/mL) and 10 × MIC (625 µg/mL), biofilm inhibitions were observed. The results were proportionally greater at the highest used concentration of EBEO (Figure 1B,C).

2.3. EBEO Is Non-Toxic towards Tenebrio molitor Larvae

The toxicity of EBEO at MIC and 10 × MIC was analyzed in T. molitor larvae. Treatment with both EBEO concentrations did not show any toxicity to these larvae, resulting in a survival curve similar to that of the larvae inoculated with 0.9% NaCl (control group) (Figure 2).

2.4. Inhibition of Streptococcus mutans Biofilm Formation on EBEO-Coated Resin Discs

Subsequently, the EBEO at MIC and 10 × MIC was used to modify the dental adhesives (Ambar APS). These adhesives were used to coat Resin composite discs (RCDs) with the following dimensions: 6 mm diameter and 1 mm thickness. The inhibition S. mutans biofilm formation was evaluated using composite resin discs either coated or not coated with adhesives containing EBEO. The results showed that the CFU from wells containing RCD without adhesive (CON) and RCD + adhesive groups (ADH) were in the order of 108 CFU/mL. On the other hand, the CFU from RCD + adhesive with EBEO at MIC (62.5 µg/mL; ADH/EBEO/62.5) was reduced by more than half compared to the control. Finally, no bacterial growth was observed in wells that contained RCD + adhesive with EBEO 10×MIC (625 µg/mL; ADH/EBEO/625) (Figure 3).
The antibacterial tests performed indicate a bactericidal effect of EBEO and S. mutans antibiofilm activity when biofilm was treated with EBEO or grown on top of adhesive-doped EBEO.

2.5. Flexural Strength (FS) and Elastic Modulus (E)

The incorporation of EBEO at different concentrations (MIC and 10×MIC), into the adhesive did not reduce the FS and E. However, increases in the values of FS and E were observed when EBEO was incorporated at the MIC (Table 1).

2.6. Degree of Conversion and Maximum Rate of Polymerization

The incorporation of EBEO into the dental adhesive at the two tested concentrations (MIC and 10×MIC) did not jeopardize the degree of conversion or maximum rate of polymerization (Table 2).
The physical-chemical properties tested indicate that the addition of EBEO in concentrations of 62.5 µg/mL and 625 µg/mL did not negatively affect the dental adhesive behavior.

3. Discussion

In this study, the action of EBEO against S. mutans was evaluated and, based on the antimicrobial effects observed, dental adhesives were developed and characterized. Natural products have been classified according to MIC value as follows: products with MIC lower than 500 μg/mL are strong inhibitors, those with MIC between 600 and 1500 μg/mL are moderate inhibitors, and those with MIC above 1600 μg/mL are weak inhibitors [28,34,35]. Data from this study indicate that EBEO is a strong inhibitor of S. mutans, with observed MIC and MBC values of 62.5 µg/mL (<500 µg/mL). These data are in accordance with the strong inhibitory effect that was also observed when EBEO was tested against Staphylococcus aureus, with MIC values ranging from 8 to 516 µg/mL [32].
Because MIC and MBC values were first evaluated with S. mutans in its planktonic form, EBEO was subjected to further testing in a more complex environment. Cells organized in biofilms present greater structural complexity and are more resistant relative to the action of antimicrobial agents [3,14]. Therefore, in this study, the antibacterial effect of EBEO was evaluated in S. mutans biofilm when diluted in culture media at MIC and 10×MIC. The EBEO at MIC (62.5 µg/mL) and 10× MIC (625 µg/mL) presented a strong reduction in S. mutans biofilm over circular coverslips, characterizing the potential to inhibit S. mutans biofilm formation, rejecting the first null hypothesis.
Invertebrate models, such as insect larvae, have been widely used in the initial prospection of antimicrobial products. Insects can be bred quickly at low cost without the need for specialized equipment, and many larvae have immune systems similar to those of mammals [36,37]. In this study, the EBEO antimicrobial activity against S. mutans in planktonic and biofilm forms, EBEO, was non-toxic in a toxicity model using T. molitor larvae, accepting the second null hypothesis. The survival of larvae inoculated with EBEO at MIC was 95%, with similar results when compared to the control group, suggesting little or no toxic effect of the components present in EBEO at MIC and 10×MIC in a larval model. Another study evaluated the toxicity of EBEO in larvae of Galleria mellonella, and the results corroborate the present study, in which no toxicity was found compared to a control group. In addition, protection was observed in larvae infected with S. aureus by EBEO [32]. These data confirm the potential therapeutic applicability of EBEO.
Following these positive results, both concentrations were incorporated into the dental adhesives. A statistically significant difference was also observed when EBEO was added to the dental adhesive for biofilm formation; the EBEO at MIC reduced the biofilm formation by 50%, whereas no bacterial growth was observed at 10×MIC, rejecting the third null hypothesis. This result suggests that even when incorporated into dental adhesives and light-cured, EBEO has antibacterial and antibiofilm properties, without its activity being mitigated by the polymer matrix.
The antibacterial and antibiofilm activities of EBEO against S. mutans can be explained by its chemical composition as EBEO is mainly composed of sesquiterpenes, such as, β-caryophyllene, α-muurolol, α-cadinol, and bicyclogermacrene [33]. In particular, the inhibitory actions of β-caryophyllene, δ-cadinene, and α-cadinol against planktonic and biofilm forms of S. mutans have been previously reported [38,39]. Although positive results were found regarding antibacterial and antibiofilm effects, restorative materials containing antimicrobial compounds should be indicated for those patients with high-caries risk. This recommendation relies on the long-term effects of these antibacterial agents on resident oral bacterial and on the clinical longevity of composite restoration due to antibacterial leaching or physical-chemical properties lowering over time [21].
In dentistry, essential oils and derivatives have been added to mouthwashes [40] and toothpaste [41] and have been used to modify resin composite [42] and dental adhesive systems [23,24,25,43]. The examples of essential oils used to modify dental adhesive include essential oil of tea tree (Terpinen-4-ol) [24] and Butia capitata Oil [23,25]. The addition of EBEO to dental adhesives did not affect the physicochemical properties of the modified adhesives, accepting the fourth null hypothesis. DG, Rpmax, FS, and E were evaluated, and the physicochemical properties tested remained stable under all concentrations. However, after the incorporation of EBEO at MIC into the dental adhesive, a small increase in its FS and E was observed, while the values for 10×MIC did not differ from those of the control group. The mechanical properties are more dependent on the crosslink density than on the degree of conversion itself [44]. Therefore, it is suggested that a lower concentration of EBEO favors the formation of these cross-links. However, this activity was not observed at a higher concentration, which was likely due to the complex composition of EBEO. Similarly, the self-etch B. capitata essential oil-doped experimental adhesives also presented antimicrobial effects in a microcosm biofilm without affecting the physicochemical properties tested excluding microtensile bond strength, which decreased after six months of storage [25].
For this reason, although promising results were obtained, future studies are still necessary to identify whether EBEO can affect the immediate and long-term dentin bond strength, the antibacterial and antibiofilm long-term effects, and the additional physicochemical properties of the dental adhesive. In addition, given the polymicrobial character of caries, another limitation of this study was the use of an in vitro bacterial mono-specie model. Thus, the excellent results obtained in vivo encourage studies with mammals in caries models with multispecies biofilm.

4. Materials and Methods

4.1. Essential Oil Obtention

EBEO was provided by the Laboratory of Natural Products of the Federal University of Pernambuco (Recife, Brazil). The procedures used for EBEO extraction and characterization are reported by Silva et al. (2015) [33].

4.2. Bacterial Suspension

S. mutans UA159 was maintained as a pure culture prior to use in the experiment. S. mutans was initially reactivated from its original culture; grown on brain heart infusion (BHI) agar plates; and incubated at 37 °C in a 10% CO2 atmosphere, for 18–24 h. Colonies were suspended in 5 mL of 0.89% NaCl solution until an absorbance of approximately 0.135 (λ = 660 nm) was reached, which is equivalent to a 1–2 × 108 colony-forming unit (CFU)/mL [28].

4.3. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC)

EBEO was tested against S. mutans to determine its MIC and MBC. In this assay, the MIC of bacterial growth and the viability of S. mutans were determined using the microdilution method in sterile 96-well culture microplates [28].
EBEO was diluted with propylene glycol. The solution was serially diluted in BHI broth to obtain a final concentration in the range of 10.0 to 1000.0 µg/mL. Subsequently, the BHI broth was inoculated with a bacterial suspension to obtain a concentration of approximately 1–2 × 105 CFU/mL. The plates were then read using a single-channel microplate reader (ASYA HITEH–UVM 340, Biochrom, Holliston, MA, USA) and incubated at 37 °C with 10% CO2 for 24 h. After incubation, absorbance at 625 nm was measured using a single-channel microplate reader. The MIC was considered the lowest concentration of EBEO at which there was no bacterial growth (absorbance reading lower than 0.05). Chlorhexidine digluconate (0.12%, final concentration) was used as the positive control, and the same vehicle and concentration were used in the preparation of the EO (25% propylene glycol) for the negative control group. The MBC was determined based on the results obtained in the MIC test, and the lowest concentration of EBEO at which no cell growth was observed on the inoculated agar surface was recorded for MBC (99.9% bacterial death). To determine the nature of the antibacterial effect of the EBEO, the MBC:MIC ratio was determined by considering the following criteria: when the MBC:MIC ratio was 1:1 or 2:1, the product was considered bactericidal; and when the ratio was greater than 2:1, the product was considered bacteriostatic [28].

4.4. Anti-Biofilm Assay on Circular Coverslip

To evaluate the antibiofilm activity of EBEO against S. mutans, 12-well microplates containing glass coverslips were used. For this, 200 µL of BHI culture medium, the bacterial inoculum at a concentration of 1 × 106 CFU/mL, glucose at a final concentration of 1%, and EBEO at the MIC and 10×MIC were added in triplicate to obtain three groups:
  • Control Group: S. mutans + BHI + 1% Glucose (CON);
  • Group 2: S mutans + BHI + 1% Glucose + EBEO in MIC (EBEO 62.5);
  • Group 3: S. mutans + BHI + 1% Glucose + EBEO 10×MIC (EBEO/625).
Subsequently, circular coverslips measuring 13 mm in diameter were inserted into the wells using sterile forceps. The plates were incubated in 10% CO2 at 37 °C for 24 h. After this period, the circular coverslips were carefully removed from the plates, washed twice with saline solution, and fixed with 200 µL of methanol for staining with 0.1% crystal violet. Following staining, the coverslips were evaluated Zeiss® Axio Imager fluorescence microscope (Zeiss, São Paulo, Brazil).

4.5. Toxicity in Tenebrio molitor Larvae

Larval stage insects were used for the EBEO toxicity assays. Groups of 20 larvae (sample size calculation recommended at least seven larvae, considering power of 0.95 and α = 0.05) [45], weighing 70–120 mg and without signs of melanization, were randomly selected and used for subsequent inoculation. A 50 μL Hamilton® syringe was used to inject 5 μL aliquots of EBEO at MIC and 10×MIC, as well as 5 μL of saline (negative control) into the hemocoel of larvae through the last left proleg. After injection, larvae were stored at room temperature, and the appearance of melanization signs and survival were recorded at selected intervals for 7 days. Larvae were classified as dead if they did not exhibit any movement in response to touch. Kaplan–Meier death curves were plotted and estimates of differences in survival were compared using a log-rank test. Statistical significance was set at p < 0.05.

4.6. Adhesive Formulation

The dental adhesive used in this study was the Ambar Advanced Polymerization System® (Ambar APS), a 5th generation (two-step total-etch) light-curing adhesive system (FGM dental group, Joinville, Brazil). The composition of this adhesive, according to the manufacturer information, is shown in Table 3. The adhesive Ambar APS was used as a vehicle to incorporate EBEO. For this, 375 µL or 37.5 µL of EBEO solution (10 mg/mL) was diluted in 6 mL of the vehicle to obtain the adhesives with EBEO at 62.5 µg/mL (MIC) or 625 µg/mL (10×MIC), respectively. The formulations were prepared using sterilized materials, in a yellow room to avoid the polymerization reaction by blue light and mixed with a mechanical agitator.

4.7. Inhibition of Streptococcus mutans Biofilm Formation on EBEO-coated Resin Discs

Resin composite discs (RCDs) were obtained (Llis, FGM, EA1), following the pattern of a mold matrix with the following dimensions: 6 mm diameter and 1 mm thickness. The composite discs were covered with a thin layer of Ambar APS adhesive with or without the EBEO, standardizing 7 µL of the adhesive on each side of the composite disc and divided into four groups (n = 4; following sample size calculation with power of 0.95 and α = 0.05) [46]:
  • Control Group: RCD without adhesive (CON);
  • Group 2: RCD + adhesive (ADH);
  • Group 3: RCD + adhesive with EBEO at MIC (ADH/EBEO/62.5);
  • Group 4: RCD + adhesive with EBEO at 10×MIC (ADH/EBEO/625).
Four RCDs were first light-cured, and 7 µL aliquots of the adhesives were light-cured under the RCDs using an LED light-curing unit (Valo, Ultradent, Indaiatuba SP, Brazil) for 20 s on each side (1200 mW/cm2). The samples were placed in 96-well microplates containing the BHI culture medium, the bacterial inoculum at a concentration of 1 × 106 CFU/mL, and glucose at a final concentration of 1%. The plates were incubated in 10% CO2 at 37 °C for 24 h. Following this period, aliquots of the culture medium were removed, diluted, and plated to count CFU/mL.

4.8. Flexural Strength (FS) and Elastic Modulus (E)

The FS and E of the dental adhesives with and without EBEO were measured. Bar-shaped specimens were obtained (12 mm × 2 mm × 2 mm) for all groups (n = 10; sample size calculation recommended at least four specimens, considering power of 0.95 and α = 0.05) using a standard stainless-steel mold [35]. The solvent was evaporated using an oil-free air jet for 10 s. The bars were light-cured, and the light cure LED units were set at a power of 1.200 mW/cm2 (Valo, Ultradent, South Jordan, UT, USA) for two overlapping exposure periods of 20 s each (20 s on the right side, 20 s on the left side). The bottom was also light-cured for an additional 20 s, and the samples were stored for 24 h under light-free, room-temperature, and dry conditions. A single operator performed all procedures.
After storage, the specimens were tested using the three-point bending method on a universal testing machine (Instron model 5844, Instron Corp., Canton, MA, USA) at a crosshead speed of 0.5 mm/min. The FS was calculated as FS = 3Fl/2bh2, where F is the load at fracture (N), l is the span length (10 mm), and b and h are the width and thickness of the specimens, respectively (mm), and expressed as MPa. The E was determined from the slope of the initial linear part of the stress-strain curve and was calculated as E = FI3/4bh3d, where F is the load at some point on the linear region of the stress-strain curve; d is the slack compensated deflection at load F; and l, b, and h are the same as defined above and expressed as GPa.
Data were subjected to the Shapiro–Wilk normality test and homoscedasticity and analyzed using one-way analysis of variance (ANOVA) followed by the Holm–Sidak post-hoc test (α = 0.05).

4.9. Degree of Conversion and Maximum Rate of Polymerization

The polymerization kinetics of adhesives with and without the incorporation of EBEO at different concentrations was monitored using Fourier transform infrared spectroscopy (FT-NIR, Vertex 70, Bruker Optics, Billerica, MA, USA) in specimens (n = 3; following sample size calculation with power of 0.95 and α = 0.05) of 5 mm diameter and 1 mm thickness between two glass slices. The solvent was evaporated for 10 s. The area of the aliphatic peak, corresponding to the carbon double bonds of the methacrylate group, centered at 6165 cm−1, was used to monitor the polymerization reaction in real time continuously for 6 min. The samples were light-cured for 20 s at an incident irradiance of 1200 mW/cm2 (Valo, Ultradent, South Jordan, UT, USA). The degree of conversion (DC) was calculated according to the formula: DC = (1 − final peak area/initial peak area) × 100%. The maximum polymerization rate (Rpmax) was calculated through the maximum point at the first derivative from the “conversion × time” curve. Data were analyzed using one-way ANOVA (α = 0.05).

5. Conclusions

Within the limitations of this in vitro study, it can be concluded that (1) EBEO presented MIC and MBC of 62.5 µg/mL; (2) EBEO showed strong antibacterial and antibiofilm activity against S. mutans; (3) EBEO showed no toxicity effect against T. molitor larvae; (4) when incorporated into a dental adhesive, EBEO held its antimicrobial activity and did not jeopardize the physical-chemical properties of the adhesive tested; and (5) the innovative EBEO-doped dental adhesives may have great promise in the prevention of recurrent caries for high-risk caries patients.

Author Contributions

Conceptualization, M.L.P.; M.V.d.S.; M.T.d.S.C.; L.C.N.d.S. and L.C.d.C.G. funding acquisition, M.V.d.S.; M.T.d.S.C. and L.C.d.C.G. investigation, M.L.P.; D.C.P.S.; C.A.M.S.J.; T.A.X.N.B.; C.M.B.F.; A.F.M.C.; F.S.F.d.S.; E.M.C.; B.M.F.; C.B.A. and L.C.d.C.G. writing—original draft, M.L.P. and writing—review and editing, C.B.A.; L.C.N.d.S. and L.C.d.C.G. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by Fundação de Amparo à Pesquisa e Desenvolvimento Científico do Maranhão (Processes numbers: POS-GRAD-02460/21, INFRA-02032/21). The researchers also received scholarships from Fundação de Amparo à Pesquisa e Desenvolvimento Científico do Maranhão, Fundação de Amparo à Ciência e Tecnologia de Pernambuco, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior e Conselho Nacional de Desenvolvimento Científico e Tecnológico.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data available upon request.

Acknowledgments

We kindly thanks the employees of CEUMA University for technical support.

Conflicts of Interest

The authors have no conflict of interest to declare.

Sample Availability

Sample available upon request.

References

  1. Valm, A.M. The Structure of Dental Plaque Microbial Communities in the Transition from Health to Dental Caries and Periodontal Disease. J. Mol. Biol. 2019, 431, 2957–2969. [Google Scholar] [CrossRef] [PubMed]
  2. Askar, H.; Krois, J.; Göstemeyer, G.; Bottenberg, P.; Zero, D.; Banerjee, A.; Schwendicke, F. Secondary caries: What is it, and how it can be controlled, detected, and managed? Clin. Oral Investig. 2020, 24, 1869–1876. [Google Scholar] [CrossRef] [PubMed]
  3. Meyer, F.; Enax, J.; Epple, M.; Amaechi, B.; Simader, B. Cariogenic Biofilms: Development, Properties, and Biomimetic Preventive Agents. Dent. J. 2021, 9, 88. [Google Scholar] [CrossRef] [PubMed]
  4. Moraes, G.S.; Cachoeira, V.S.; Alves, F.M.C.; Kiratcz, F.; Albach, T.; Bueno, M.G.; Neppelenbroek, K.H.; Urban, V.M. Is there an optimal method to detach Candida albicans biofilm from dental materials? J. Med. Microbiol. 2021, 70, 001436. [Google Scholar] [CrossRef]
  5. Hardan, L.; Bourgi, R.; Cuevas-Suárez, C.; Zarow, M.; Kharouf, N.; Mancino, D.; Villares, C.; Skaba, D.; Lukomska-Szymanska, M. The Bond Strength and Antibacterial Activity of the Universal Dentin Bonding System: A Systematic Review and Meta-Analysis. Microorganisms 2021, 9, 1230. [Google Scholar] [CrossRef]
  6. Lemos, J.A.; Burne, R.A. A model of efficiency: Stress tolerance by Streptococcus mutans. Microbiology 2008, 154, 3247–3255. [Google Scholar] [CrossRef]
  7. Martignon, S.; Roncalli, A.G.; Alvarez, E.; Aránguiz, V.; Feldens, C.A.; Buzalaf, M.A.R. Risk factors for dental caries in Latin American and Caribbean countries. Braz. Oral Res. 2021, 35, e053. [Google Scholar] [CrossRef]
  8. Bowen, W.H.; Koo, H. Biology of Streptococcus mutans-Derived Glucosyltransferases: Role in Extracellular Matrix Formation of Cariogenic Biofilms. Caries Res. 2011, 45, 69–86. [Google Scholar] [CrossRef]
  9. Lemos, J.A.; Palmer, S.R.; Zeng, L.; Wen, Z.T.; Kajfasz, J.K.; Freires, I.A.; Abranches, J.; Brady, L.J. The Biology of Streptococcus mutans. Microbiol. Spectr. 2019, 7. [Google Scholar] [CrossRef]
  10. Wu, R.; Tao, Y.; Cao, Y.; Zhou, Y.; Lin, H. Streptococcus mutans Membrane Vesicles Harboring Glucosyltransferases Augment Candida albicans Biofilm Development. Front. Microbiol. 2020, 11, 581184. [Google Scholar] [CrossRef]
  11. Abranches, J.; Miller, J.H.; Martinez, A.R.; Simpson-Haidaris, P.J.; Burne, R.A.; Lemos, J.A. The Collagen-Binding Protein Cnm Is Required for Streptococcus mutans Adherence to and Intracellular Invasion of Human Coronary Artery Endothelial Cells. Infect. Immun. 2011, 79, 2277–2284. [Google Scholar] [CrossRef]
  12. Kajfasz, J.K.; Rivera-Ramos, I.; Abranches, J.; Martinez, A.R.; Rosalen, P.L.; Derr, A.M.; Quivey, R.G.; Lemos, J.A. Two Spx Proteins Modulate Stress Tolerance, Survival, and Virulence in Streptococcus mutans. J. Bacteriol. 2010, 192, 2546–2556. [Google Scholar] [CrossRef] [PubMed]
  13. Ferracane, J.L. Resin-based composite performance: Are there some things we can’t predict? Dent. Mater. 2013, 29, 51–58. [Google Scholar] [CrossRef] [PubMed]
  14. Yaghmoor, R.B.; Xia, W.; Ashley, P.; Allan, E.; Young, A.M. Effect of Novel Antibacterial Composites on Bacterial Biofilms. J. Funct. Biomater. 2020, 11, 55. [Google Scholar] [CrossRef] [PubMed]
  15. Lygidakis, N.N.; Allan, E.; Xia, W.; Ashley, P.F.; Young, A.M. Early Polylysine Release from Dental Composites and Its Effects on Planktonic Streptococcus mutans Growth. J. Funct. Biomater. 2020, 11, 53. [Google Scholar] [CrossRef]
  16. Andre, C.; Chan, D.C.; Giannini, M. Antibacterial-containing dental adhesives’ effects on oral pathogens and on Streptococcus mutans biofilm: Current perspectives. Am. J. Dent. 2018, 31, 37B–41B. [Google Scholar]
  17. Cocco, A.R.; Rosa, W.L.D.O.D.; da Silva, A.F.; Lund, R.G.; Piva, E. A systematic review about antibacterial monomers used in dental adhesive systems: Current status and further prospects. Dent. Mater. 2015, 31, 1345–1362. [Google Scholar] [CrossRef]
  18. Freitas, P.H.; André, C.B.; Fronza, B.M.; Giannini, M.; Rosalen, P.L.; Consani, S.; França, R. Physicochemical properties, metalloproteinases inhibition, and antibiofilm activity of doxycycline-doped dental adhesive. J. Dent. 2021, 104, 103550. [Google Scholar] [CrossRef]
  19. Makvandi, P.; Jamaledin, R.; Jabbari, M.; Nikfarjam, N.; Borzacchiello, A. Antibacterial quaternary ammonium compounds in dental materials: A systematic review. Dent. Mater. 2018, 34, 851–867. [Google Scholar] [CrossRef]
  20. Boaro, L.C.C.; Campos, L.M.; Varca, G.H.C.; dos Santos, T.M.R.; Marques, P.A.; Sugii, M.M.; Saldanha, N.R.; Cogo-Müller, K.; Brandt, W.C.; Braga, R.R.; et al. Antibacterial resin-based composite containing chlorhexidine for dental applications. Dent. Mater. 2019, 35, 909–918. [Google Scholar] [CrossRef]
  21. André, C.B.; Rosalen, P.L.; Giannini, M.; Bueno-Silva, B.; Pfeifer, C.S.; Ferracane, J.L. Incorporation of Apigenin and tt-Farnesol into dental composites to modulate the Streptococcus mutans virulence. Dent. Mater. 2021, 37, e201–e212. [Google Scholar] [CrossRef]
  22. André, C.B.; Rosalen, P.L.; Galvão, L.C.D.C.; Fronza, B.M.; Ambrosano, G.M.B.; Ferracane, J.L.; Giannini, M. Modulation of Streptococcus mutans virulence by dental adhesives containing anti-caries agents. Dent. Mater. 2017, 33, 1084–1092. [Google Scholar] [CrossRef]
  23. Peralta, S.L.; de Carvalho, P.H.A.; Ccahuana-Vásquez, R.A.; de Pereira, C.M.P.; Cury, J.A.; Piva, E.; Lund, R.G. Cytotoxicity, genotoxicity and antibiofilm activity on Streptococcus mutans of an experimental self-etching adhesive system containing natural Butia capitata oil. Int. J. Adhes. Adhes. 2017, 78, 95–101. [Google Scholar] [CrossRef]
  24. Cocco, A.R.; Maske, T.T.; Lund, R.G.; Moraes, R.R. The antibacterial and physicochemical properties of a one-step dental adhesive modified with potential antimicrobial agents. Int. J. Adhes. Adhes. 2016, 71, 74–80. [Google Scholar] [CrossRef]
  25. Peralta, S.; Carvalho, P.H.; van de Sande, F.; de Pereira, C.M.P.; Piva, E.; Lund, R.G. Self-etching dental adhesive containing a natural essential oil: Anti-biofouling performance and mechanical properties. Biofouling 2013, 29, 345–355. [Google Scholar] [CrossRef]
  26. Mittal, R.P.; Rana, A.; Jaitak, V. Essential Oils: An Impending Substitute of Synthetic Antimicrobial Agents to Overcome Antimicrobial Resistance. Curr. Drug Targets 2019, 20, 605–624. [Google Scholar] [CrossRef]
  27. Spengler, G.; Gajdács, M.; Donadu, M.G.; Usai, M.; Marchetti, M.; Ferrari, M.; Mazzarello, V.; Zanetti, S.; Nagy, F.; Kovács, R. Evaluation of the Antimicrobial and Antivirulent Potential of Essential Oils Isolated from Juniperus oxycedrus L. ssp. macrocarpa Aerial Parts. Microorganisms 2022, 10, 758. [Google Scholar] [CrossRef]
  28. Galvão, L.C.D.C.; Furletti, V.F.; Bersan, S.M.F.; da Cunha, M.G.; Ruiz, A.L.T.G.; de Carvalho, J.E.; Sartoratto, A.; Rehder, V.L.G.; Figueira, G.M.; Duarte, M.C.T.; et al. Antimicrobial Activity of Essential Oils against Streptococcus mutansand their Antiproliferative Effects. Evid.-Based Complement. Altern. Med. 2012, 2012, 751435. [Google Scholar] [CrossRef]
  29. Da Costa, J.S.; Cruz, E.D.N.S.D.; Setzer, W.N.; Da Silva, J.K.D.R.; Maia, J.G.S.; Figueiredo, P.L.B. Essentials Oils from Brazilian Eugenia and Syzygium Species and Their Biological Activities. Biomolecules 2020, 10, 1155. [Google Scholar] [CrossRef]
  30. Mazine, F.F.; Souza, V.C. A new species of Eugenia (Myrtaceae) from north-eastern Brazil. Bot. J. Linn. Soc. 2008, 158, 775–777. [Google Scholar] [CrossRef]
  31. Mendes, J.F.; Martins, H.H.A.; Otoni, C.G.; Santana, N.A.; Silva, R.C.S.; Da Silva, A.G.; Silva, M.V.; Correia, M.T.S.; Machado, G.; Pinheiro, A.C.M.; et al. Chemical composition and antibacterial activity of Eugenia brejoensis essential oil nanoemulsions against Pseudomonas fluorescens. LWT 2018, 93, 659–664. [Google Scholar] [CrossRef]
  32. Filho, C.M.B.; da Silva, L.C.N.; da Silva, M.V.; Løbner-Olesen, A.; Struve, C.; Krogfelt, K.A.; Correia, M.T.D.S.; Oliva, M.L.V. Antimicrobial and Antivirulence Action of Eugenia brejoensis Essential Oil in vitro and in vivo Invertebrate Models. Front. Microbiol. 2020, 11, 424. [Google Scholar] [CrossRef] [PubMed]
  33. Da Silva, A.G.; Alves, R.C.C.; Filho, C.M.B.; Bezerra-Silva, P.C.; Dos Santos, L.M.M.; Foglio, M.A.; Navarro, D.M.D.A.F.; Da Silva, M.V.; Correia, M.T.D.S. Chemical Composition and Larvicidal Activity of the Essential Oil from Leaves of Eugenia brejoensis Mazine (Myrtaceae). J. Essent. Oil Bear. Plants 2015, 18, 1441–1447. [Google Scholar] [CrossRef]
  34. Aligiannis, N.; Kalpoutzakis, E.; Mitaku, S.; Chinou, I.B. Composition and Antimicrobial Activity of the Essential Oils of Two Origanum Species. J. Agric. Food Chem. 2001, 49, 4168–4170. [Google Scholar] [CrossRef]
  35. Fonseca, B.M.; Barcellos, D.C.; Da Silva, T.M.; Borges, A.L.S.; Cavalcanti, B.D.N.; Prakki, A.; De Oliveira, H.P.M.; Gonçalves, S.E.D.P. Mechanical-physicochemical properties and biocompatibility of catechin-incorporated adhesive resins. J. Appl. Oral Sci. 2019, 27. [Google Scholar] [CrossRef]
  36. Ebenaducci, T.; Sardi, J.D.C.O.; Lourencetti, N.M.S.; Scorzoni, L.; Egullo, F.P.; Erossi, S.A.; Derissi, J.B.; Prata, M.C.D.A.; Efusco-Almeida, A.M.; Mendes-Giannini, M.J.S. Virulence of Cryptococcus sp. Biofilms In Vitro and In Vivo using Galleria mellonella as an Alternative Model. Front. Microbiol. 2016, 7, 290. [Google Scholar] [CrossRef]
  37. Ignasiak, K.; Maxwell, A. Galleria mellonella (greater wax moth) larvae as a model for antibiotic susceptibility testing and acute toxicity trials. BMC Res. Notes 2017, 10, 428. [Google Scholar] [CrossRef]
  38. Yoo, H.-J.; Jwa, S. Inhibitory effects of β-caryophyllene on Streptococcus mutans biofilm. Arch. Oral Biol. 2018, 88, 42–46. [Google Scholar] [CrossRef]
  39. Kubo, I.; Muroi, H.; Kubo, A. Antibacterial activity of long-chain alcohols against Streptococcus mutans. J. Agric. Food Chem. 1993, 41, 2447–2450. [Google Scholar] [CrossRef]
  40. Dimou, I.; Dritsas, S.; Aggelopoulou, P.; Vassilatou, K.; Damianaki, S.; Giaouris, E. Development of a herbal mouthwash containing a mixture of essential oils and plant extracts and in vitro testing of its antimicrobial efficiency against the planktonic and biofilm-enclosed cariogenic bacterium Streptococcus mutans. Biofouling 2021, 37, 397–409. [Google Scholar] [CrossRef]
  41. De Oliveira Carvalho, I.; Purgato, G.A.; Píccolo, M.S.; Pizziolo, V.R.; Coelho, R.R.; Diaz-Muñoz, G.; Diaz, M.A.N. In vitro anticariogenic and antibiofilm activities of toothpastes formulated with essential oils. Arch. Oral Biol. 2020, 117, 104834. [Google Scholar] [CrossRef]
  42. Lapinska, B.; Szram, A.; Zarzycka, B.; Grzegorczyk, J.; Hardan, L.; Sokolowski, J.; Lukomska-Szymanska, M. An In Vitro Study on the Antimicrobial Properties of Essential Oil Modified Resin Composite against Oral Pathogens. Materials 2020, 13, 4383. [Google Scholar] [CrossRef] [PubMed]
  43. Almaroof, A.; Niazi, S.A.; Rojo, L.; Mannocci, F.; Deb, S. Evaluation of dental adhesive systems incorporating an antibacterial monomer eugenyl methacrylate (EgMA) for endodontic restorations. Dent. Mater. 2017, 33, e239–e254. [Google Scholar] [CrossRef]
  44. Dauvillier, B.S.; Feilzer, A.J.; De Gee, A.J.; Davidson, C.L. Visco-elastic Parameters of Dental Restorative Materials during Setting. J. Dent. Res. 2000, 79, 818–823. [Google Scholar] [CrossRef]
  45. Amorim, E.A.D.F.; Castro, E.J.M.; Da Souza, S.V.; Alves, M.S.; Dias, L.R.L.; Melo, M.H.F.; Da Silva, I.M.A.; Villis, P.C.M.; Bonfim, M.R.Q.; Falcai, A.; et al. Antimicrobial Potential of Streptomyces ansochromogenes (PB3) Isolated From a Plant Native to the Amazon Against Pseudomonas aeruginosa. Front. Microbiol. 2020, 11, 574693. [Google Scholar] [CrossRef]
  46. Kim, S.; Song, M.; Roh, B.-D.; Park, S.-H.; Park, J.-W. Inhibition of Streptococcus mutans biofilm formation on composite resins containing ursolic acid. Restor. Dent. Endod. 2013, 38, 65–72. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Biofilm of Streptococcus mutans on circular coverslip. (A) CON. (B) EBEO at 62.5 µg/mL (MIC). (C) EOEB at 625 µg/mL (10 × MIC). Biofilm marked with crystal violet appear in purple.
Figure 1. Biofilm of Streptococcus mutans on circular coverslip. (A) CON. (B) EBEO at 62.5 µg/mL (MIC). (C) EOEB at 625 µg/mL (10 × MIC). Biofilm marked with crystal violet appear in purple.
Jfb 13 00149 g001
Figure 2. Percent survival of Tenebrio molitor larvae exposed to EBEO at MIC and 10×MIC concentrations. Kaplan–Meier death curves were plotted and estimates of differences in survival were compared using a log-rank test. Curves with the same pattern indicate no significant difference.
Figure 2. Percent survival of Tenebrio molitor larvae exposed to EBEO at MIC and 10×MIC concentrations. Kaplan–Meier death curves were plotted and estimates of differences in survival were compared using a log-rank test. Curves with the same pattern indicate no significant difference.
Jfb 13 00149 g002
Figure 3. Viability of S. mutans in wells containing composite resin discs with and without dental adhesives tested. (***) Indicate significant difference from CON group.
Figure 3. Viability of S. mutans in wells containing composite resin discs with and without dental adhesives tested. (***) Indicate significant difference from CON group.
Jfb 13 00149 g003
Table 1. Flexural strength and elastic modulus of adhesives tested.
Table 1. Flexural strength and elastic modulus of adhesives tested.
GroupsFS (MPa)E (GPa)
Adhesive (control group)40.9 (±5.3) a0.16 (±0.01) a
Adhesive + EBEO (62.5 µg/mL)51.8 (±6.6) b0.20 (±0.02) b
Adhesive + EBEO (625 µg/mL)42.3 (±3.4) a0.16 (±0.01) a
In each column, different superscript letters (a, b) indicate significant difference (p < 0.05).
Table 2. Degree of conversion (DC) and maximum polymerization rate (Rpmax) of tested adhesives.
Table 2. Degree of conversion (DC) and maximum polymerization rate (Rpmax) of tested adhesives.
GroupsDC (%)Rpmax (%/s)
Adhesive (control group)94.6 (±3.1) a16.4 (1.5) a
Adhesive + EBEO (62.5 µg/mL)94.5 (2.2) a18.6 (2.3) a
Adhesive + EBEO (625 µg/mL)94.8 (0.5) a18.9 (0.9) a
In each column, the same superscript letter (a) indicates no significant difference (p > 0.05).
Table 3. Adhesive composition.
Table 3. Adhesive composition.
Components
Ambar APSUrethane dimethacrylate glycerol dimethacrylate.
2-Hidroxyethylmethacrylate
Ethanol
10-Methacryloyoxydecyl dihydrogen phosphate
Ethyl 4-(Dimethylamino) Benzoate
Adhesive monomer (under patent protection)
Antioxidant (under patent protection)
Camphorquinone
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Pereira, M.L.; Santos, D.C.P.; Soares Júnior, C.A.M.; Bazan, T.A.X.N.; Bezerra Filho, C.M.; Silva, M.V.d.; Correia, M.T.d.S.; Cardenas, A.F.M.; Siqueira, F.S.F.d.; Carvalho, E.M.; et al. Development and Physicochemical Characterization of Eugenia brejoensis Essential Oil-Doped Dental Adhesives with Antimicrobial Action towards Streptococcus mutans. J. Funct. Biomater. 2022, 13, 149. https://doi.org/10.3390/jfb13030149

AMA Style

Pereira ML, Santos DCP, Soares Júnior CAM, Bazan TAXN, Bezerra Filho CM, Silva MVd, Correia MTdS, Cardenas AFM, Siqueira FSFd, Carvalho EM, et al. Development and Physicochemical Characterization of Eugenia brejoensis Essential Oil-Doped Dental Adhesives with Antimicrobial Action towards Streptococcus mutans. Journal of Functional Biomaterials. 2022; 13(3):149. https://doi.org/10.3390/jfb13030149

Chicago/Turabian Style

Pereira, Maury Luz, Danyelle Cristina Pereira Santos, Carlos Alberto Mendes Soares Júnior, Tamyris Alicely Xavier Nogueira Bazan, Clovis Macêdo Bezerra Filho, Márcia Vanusa da Silva, Maria Tereza dos Santos Correia, Andres Felipe Millan Cardenas, Fabiana Suelen Figuerêdo de Siqueira, Edilausson Moreno Carvalho, and et al. 2022. "Development and Physicochemical Characterization of Eugenia brejoensis Essential Oil-Doped Dental Adhesives with Antimicrobial Action towards Streptococcus mutans" Journal of Functional Biomaterials 13, no. 3: 149. https://doi.org/10.3390/jfb13030149

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop